Morlat, Philippe
2 papers on CoChat
Most cited papers
- Verified
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial
Moyle, G., Assoumou, L., de Castro, N., Post, F. A., Curran, A., Rusconi, S., De Wit, S., Stephan, C., Raffi, F., Johnson, M., et al. (2024) · The Lancet HIV
HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions
Cited by 6
- Verified
False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers
Hage-Sleiman, M., Tremeaux, P., Fillion, M., Boufassa, F., Melard, A., Gardiennet, E., Mariaggi, A.-A., Plantier, J.-C., Rouzioux, C., Lambotte, O., et al. (2020) · Clinical Infectious Diseases
HIV Research and TreatmentHIV/AIDS Research and Interventions
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free